Literature DB >> 7916238

The use of molecular genetic analysis in the diagnosis of renal cell carcinoma.

J P Long1, P Anglard, J R Gnarra, M M Walther, M J Merino, S Liu, M I Lerman, B Zbar, W M Linehan.   

Abstract

The most common genetic aberration seen in nonpapillary renal cell carcinoma is believed to be the loss or inactivation of allelic material on the short arm of chromosome 3 (3p). Two patients underwent nephrectomy at our institution, each initially receiving a histologic diagnosis of renal cell carcinoma. Molecular analysis of these tissues revealed no genetic deletion on 3p, prompting further histologic and immunohistochemical evaluation of the original specimens. These additional studies confirmed alternate histologies other than renal cell carcinoma in each case. These data suggest that the loss of genetic material on the short arm of chromosome 3 may be specific for nonpapillary renal cell carcinoma. Molecular analysis may prove to be a useful adjunct in establishing the diagnosis in renal neoplasms with equivocal histologies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916238     DOI: 10.1007/bf00184239

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  39 in total

1.  Localization of polymorphic DNA probes frequently deleted in lung carcinoma.

Authors:  D G Albertson; P D Sherrington; P H Rabbitts
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

2.  Improved detection of allele loss in renal cell carcinomas after removal of leukocytes by immunologic selection.

Authors:  M Linehan; E Miller; P Anglard; M Merino; B Zbar
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

3.  A genetic linkage map of the human genome.

Authors:  H Donis-Keller; P Green; C Helms; S Cartinhour; B Weiffenbach; K Stephens; T P Keith; D W Bowden; D R Smith; E S Lander
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

4.  Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. I.

Authors:  G M Farrow; E G Harrison; D C Utz; W H ReMine
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

5.  Collecting duct carcinoma of the kidney.

Authors:  S Fleming; H J Lewi
Journal:  Histopathology       Date:  1986-11       Impact factor: 5.087

6.  Allelotype of renal cell carcinoma.

Authors:  R Morita; J Ishikawa; M Tsutsumi; K Hikiji; Y Tsukada; S Kamidono; S Maeda; Y Nakamura
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

7.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

9.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

10.  Molecular analysis of the short arm of chromosome 3 in five renal oncocytomas.

Authors:  H Brauch; K Tory; W M Linehan; D J Weaver; M A Lovell; B Zbar
Journal:  J Urol       Date:  1990-03       Impact factor: 7.450

View more
  2 in total

1.  Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma.

Authors:  Michael J Hamilton; Thomas Girke; Ernest Martinez
Journal:  Oncotarget       Date:  2018-05-04

2.  Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma.

Authors:  Hakushi Kim; Tomoyoshi Komiyama; Chie Inomoto; Hiroshi Kamiguchi; Hiroshi Kajiwara; Hiroyuki Kobayashi; Naoya Nakamura; Toshiro Terachi
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.